MedTech Interviews

Building on a solid scientific basis, US based CaP Biomaterials transformed into leading Calcium Phosphate contract manufacturer with global reach

Named in BONEZONE as a leading US-based contract manufacturer of calcium phosphates for medical devices, CaP Biomaterials manufactures custom materials

• Guillaume Viallaneix / 1 week
• (6.57K)

Hospitals Are Losing Surgeons. Hellstern Medical Built the Fix

Surgeons generate up to 70 percent of a hospital’s revenue, yet three in four report pain and fatigue in the

• Guillaume Viallaneix / 2 weeks
• (6.60K)

Predictable Setups, Reliable Execution: David Holdford on Building IOS for the Real World of Radiation Oncology

From patient positioning and immobilization to workflow fit and reproducible radiotherapy setups, David Holdford has helped build a company around

• Guillaume Viallaneix / 3 months
• (6.59K)

No More Guesswork: Philip Gower on How Headsafe Is Changing the Way America Diagnoses Concussions

Headsafe's Chief Strategy & Commercial Officer has built Inc. 5000 companies, navigated exits, and mentored a generation of healthcare leaders.

• Guillaume Viallaneix / 4 months
• (6.33K)

From Leipzig to the OR: How REALISTS Is Bringing Next-Generation Spine Simulation to the United States

Some of the most compelling stories in MedTech don't start in a boardroom. They start with a problem no one

• Guillaume Viallaneix / 4 months
• (6.22K)

The Microscope Is in Another Room. Again.

Hand surgeon Dr. Kevin Malone on why cost, portability, and access to magnification define the future of surgical care —

• Guillaume Viallaneix / 4 months
• (6.25K)

Douglas Carroll, President & CEO of Unify Medical: How a 101st Airborne Veteran Turned Six MedTech Exits Into the World’s First Wearable Surgical Microscope

The man who helped build a $701M exit to Stryker is now bringing affordable wearable surgical magnification to hospitals, ambulatory

• Guillaume Viallaneix / 5 months
• (6.37K)

Headsafe’s New CEO on Making Objective Concussion Assessment Routine Care

How Craig Corrance plans to bring Nurochek to the frontlines of mild Traumatic Brain Injury care  

• Guillaume Viallaneix / 7 months
• (6.38K)

Karl Neuberger on the Work That Makes, or Breaks, a Device Market Launch

Millstone CEO Karl Neuberger on the readiness work OEM teams cannot afford to treat as an afterthought, and why “one

• Guillaume Viallaneix / 8 months
• (5.69K)

Beyond the Merger: EXALTA Raises the Bar for Integrated, Scalable MedTech Partnerships

From legacy brands to a unified vision, CEO Olivier Wolber shares how EXALTA’s integration is unlocking new value for customers

• Guillaume Viallaneix / 8 months
• (7.24K)